In a new review published Monday, Food and Drug Administration scientists said that COVID-19 booster shots aren’t needed for the general population. The authors included Dr. Philip Krause and Dr. Marion Gruber, both of whom will be leaving the agency. (The New York Times)
President Biden’s vaccination mandate for private employers is dependent on an emergency temporary standard that will be issued in the next few weeks. But some Republican state governors have already threatened lawsuits over the plan. (Reuters)
AbbVie is acquiring a new gene therapy from Regenxbio for $370 million in cash. The therapy aims to encode an antibody fragment into the eyes of patients with wet age-related macular degeneration. (Endpoints News)
Cancer drug product labels kept benefits listed even after later studies didn’t verify them, according to new research. The drugs had gone through the accelerated approval program, raising concerns that the speedy approvals system may be “broken,” the study co-author noted. (STAT)
New York City’s public schools, encompassing some one million students, are fully reopening with in-person classes this week. The city’s 300,000 employees will also be returning to offices. (AP)
